1. Interprofessional Approaches: Managing AEs of Novel Therapies for NHL/CLL

3. Treatment of NHL/CLL

4. Ibrutinib

5. Ibrutinib Common AEs

6. Ibrutinib Common AEs (cont)

7. Ibrutinib Common AEs (cont)

8. Ibrutinib: Life-Long Therapy Facilitating Long-Term Adherence

9. Idelalisib

10. Idelalisib (cont)

11. Idelalisib Managing Diarrhea

12. Idelalisib (cont)

13. Venetoclax

14. Cairo-Bishop Definition of Laboratory TLS for Adults

15. TLS Risk Assessment for Lymphomas

16. Managing Venetoclax-Related TLS Use in High-Risk Patients

17. Venetoclax Mitigating Additional Risks

18. Obinutuzumab

19. Obinutuzumab Additional Risks

20. Working With Patients Over the Long Term It Takes an Army

21. Shared Decision-Making for Mitigating and Managing AEs

22. Abbreviations

23. Abbreviations (cont)